- 全部删除
您的购物车当前为空
Imlunestrant (LY-3484356) 是一种口服有效的和选择性的雌激素受体(estrogen receptor)降解剂,能够持续抑制ER依赖基因转录和细胞生长,可用于研究er阳性、her2阴性、esr1突变的晚期或转移性乳腺癌。

Imlunestrant (LY-3484356) 是一种口服有效的和选择性的雌激素受体(estrogen receptor)降解剂,能够持续抑制ER依赖基因转录和细胞生长,可用于研究er阳性、her2阴性、esr1突变的晚期或转移性乳腺癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 413 | In stock | |
| 5 mg | ¥ 987 | In stock | |
| 10 mg | ¥ 1,650 | In stock | |
| 25 mg | ¥ 2,980 | In stock | |
| 50 mg | ¥ 4,180 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,190 | In stock |
Imlunestrant 相关产品
| 产品描述 | Imlunestrant (LY-3484356) is an orally active, selective estrogen receptor degrader that persistently inhibits ER-dependent gene transcription and cell growth. It is suitable for investigating ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. |
| 体外活性 | Imlunestrant 具有良好的药代动力学 (PK) 特性,包括在 ESR1 突变体中的抗肿瘤活性[1]。 |
| 别名 | 依仑司群, LY-3484356, LY3484356 |
| 分子量 | 524.51 |
| 分子式 | C29H24F4N2O3 |
| CAS No. | 2408840-26-4 |
| 颜色 | Orange |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 140 mg/mL (266.92 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容